These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26369014)

  • 21. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
    Al-Jamal WT; Kostarelos K
    Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy.
    Rahman M; Akhter S; Ahmad J; Ahmad MZ; Beg S; Ahmad FJ
    Expert Opin Drug Deliv; 2015 Apr; 12(4):635-52. PubMed ID: 25439967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advancements in Rectal Drug Delivery Systems: Clinical Trials, and Patents Perspective.
    Rathi R; Sanshita ; Kumar A; Vishvakarma V; Huanbutta K; Singh I; Sangnim T
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Advances in novel carrier systems of chemical constituents from spice volatile oils].
    Zhang JJ; Zhu Y; Yu JN; Xu XM
    Zhongguo Zhong Yao Za Zhi; 2015 Oct; 40(20):3932-6. PubMed ID: 27062804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review.
    Nouri Z; Hajialyani M; Izadi Z; Bahramsoltani R; Farzaei MH; Abdollahi M
    Front Bioeng Biotechnol; 2020; 8():425. PubMed ID: 32478050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reassessing bioavailability of silymarin.
    Javed S; Kohli K; Ali M
    Altern Med Rev; 2011 Sep; 16(3):239-49. PubMed ID: 21951025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dermal and Transdermal Drug Delivery through Vesicles and Particles: Preparation and Applications.
    Garg U; Jain K
    Adv Pharm Bull; 2022 Jan; 12(1):45-57. PubMed ID: 35517881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin cancer: symptoms, mechanistic pathways and treatment rationale for therapeutic delivery.
    Goyal N; Thatai P; Sapra B
    Ther Deliv; 2017 Mar; 8(5):265-287. PubMed ID: 28361609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids.
    Fattal E; De Rosa G; Bochot A
    Int J Pharm; 2004 Jun; 277(1-2):25-30. PubMed ID: 15158966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nano-scale drug delivery systems for antiarrhythmic agents.
    Nadimi AE; Ebrahimipour SY; Afshar EG; Falahati-Pour SK; Ahmadi Z; Mohammadinejad R; Mohamadi M
    Eur J Med Chem; 2018 Sep; 157():1153-1163. PubMed ID: 30189397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications.
    Capretto L; Carugo D; Mazzitelli S; Nastruzzi C; Zhang X
    Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1496-532. PubMed ID: 23933616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethosomes and Transfersomes: Principles, Perspectives and Practices.
    Garg V; Singh H; Bimbrawh S; Singh SK; Gulati M; Vaidya Y; Kaur P
    Curr Drug Deliv; 2017; 14(5):613-633. PubMed ID: 27199229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review on Different Vesicular Drug Delivery Systems (VDDSs) and Their Applications.
    Alenzi AM; Albalawi SA; Alghamdi SG; Albalawi RF; Albalawi HS; Qushawy M
    Recent Pat Nanotechnol; 2023; 17(1):18-32. PubMed ID: 35227188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies.
    Haeri A; Osouli M; Bayat F; Alavi S; Dadashzadeh S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1-14. PubMed ID: 29186990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomedicine and therapy of lung diseases.
    Garcia Fde M
    Einstein (Sao Paulo); 2014; 12(4):531-3. PubMed ID: 25628213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concepts and Strategies for the Site Specific Delivery of Nanocarrier Based Delivery Systems for Treating Hepatocellular Carcinoma.
    Sharma P; Pandita A; Murthy RS
    Curr Drug Deliv; 2013 Nov; ():. PubMed ID: 24266510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives.
    Khan J; Alexander A; Ajazuddin ; Saraf S; Saraf S
    J Control Release; 2013 May; 168(1):50-60. PubMed ID: 23474031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Drug Delivery Systems for Loading of Natural Plant Extracts and Their Biomedical Applications.
    Rahman HS; Othman HH; Hammadi NI; Yeap SK; Amin KM; Abdul Samad N; Alitheen NB
    Int J Nanomedicine; 2020; 15():2439-2483. PubMed ID: 32346289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotheranostics and image-guided drug delivery: current concepts and future directions.
    Lammers T; Kiessling F; Hennink WE; Storm G
    Mol Pharm; 2010 Dec; 7(6):1899-912. PubMed ID: 20822168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticle formulations in pulmonary drug delivery.
    Bailey MM; Berkland CJ
    Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.